Arcturus Therapeutics In...

NASDAQ: ARCT · Real-Time Price · USD
19.48
0.25 (1.30%)
At close: Aug 15, 2025, 3:59 PM
19.70
1.10%
After-hours: Aug 15, 2025, 06:45 PM EDT

Arcturus Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
138.39M 157.75M 205.75M 12.36M
Cost of Revenue
3.54M 2.96M 143.05M 173.76M
Gross Profit
134.84M 154.79M 58.25M -161.4M
Operating Income
-95.67M -78.2M 12.18M -202.85M
Interest Income
15.2M 17.36M 2.58M 753K
Pretax Income
-80.94M -27.89M 10.64M -203.67M
Net Income
-80.94M -29.73M 9.35M -203.67M
Selling & General & Admin
52.82M 52.87M 46.07M 41.45M
Research & Development
195.16M 192.13M 147.75M 173.76M
Other Expenses
-74.01M -192.13M -147.75M -173.76M
Operating Expenses
173.97M 52.87M 46.07M 41.45M
Interest Expense
n/a 767K 3M 2.67M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
177.51M 161.9M 193.58M 215.21M
Income Tax Expense
-4K 1.83M 1.29M 3.19M
Shares Outstanding (Basic)
27M 26.63M 26.45M 26.32M
Shares Outstanding (Diluted)
27M 26.63M 27.09M 26.32M
EPS (Basic)
-3 -1.12 0.35 -7.74
EPS (Diluted)
-3 -1.12 0.35 -7.74
EBITDA
-77.4M -24.17M 13.7M -201.66M
EBIT
-80.94M -27.12M 12.18M -202.85M
Depreciation & Amortization
3.54M 2.96M 1.53M 1.19M